InControl cuts 10% of staff
This article was originally published in Clinica
Around 10% of InControl's workforce worldwide are to lose their jobs as the US cardiac device company carries out organisational changes. The restructuring is aimed at cutting costs at its European distribution operation and improving the efficiency of the US business. Most of the cuts will be in administrative positions in Europe.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.